Status | Study |
Recruiting |
Study Name: A Study to Characterize the Cardiac Phenotype of Individuals With Friedreich's Ataxia (CARFA Study) Condition: Friedreich's Ataxia Date: 2016-07-19 Interventions: Procedure: Cardiac magnetic resonance imaging (CMR) |
Recruiting |
Study Name: A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome Condition: Wolfram Syndrome Diabetes Mellitus Optic Nerve Atrophy Date: 2016-07-06 Interventions: Drug: dantrolene sodium The purpose of this study is to as |
Recruiting |
Study Name: Wolfram Syndrome International Registry and Clinical Study Condition: Wolfram Syndrome Diabetes Mellitus Optic Nerve Atrophy Date: 2016-07-06 |
Completed |
Study Name: STEADFAST Long-Term Safety Extension Condition: Friedreich's Ataxia Date: 2016-06-02 Interventions: Drug: interferon γ-1b ACTIMMUNE® will be administered three times per week by subcutaneous inj |
Recruiting |
Study Name: EDS in Ataxia Telangiectasia Patients Condition: Nervous System Disease Genetic Syndrome Date: 2016-05-02 Interventions: Drug: EDS-EP dose range of ~5-10 mg DSP/infusion |
Recruiting |
Study Name: Natural History of Spinocerebellar Ataxia Type 7 (SCA7) Condition: Spinocerebellar Ataxia Date: 2016-04-13 |
Recruiting |
Study Name: Response of Individuals With Ataxia-Telangiectasia to Metformin and Pioglitazone Condition: Ataxia-Telangiectasia Date: 2016-03-31 Interventions: Drug: Metformin Metformin will |
Recruiting |
Study Name: Rosuvastatin (Crestor) in Friedreich Ataxia Condition: Friedreich Ataxia Date: 2016-03-05 Interventions: Drug: Rosuvastatin Daily oral administration of Rosuvastatin (10 mg) for 3 months |
Completed |
Study Name: A Safety Study of NNZ-2566 in Pediatric Rett Syndrome Condition: Rett Syndrome Date: 2016-02-21 Interventions: Drug: NNZ-2566 Glycyl-L-2-Meth |
Recruiting |
Study Name: Sporadic Degenerative Ataxia With Adult Onset: Natural History Study Condition: Late Onset Sporadic Cerebellar Ataxia Date: 2016-01-28 |